D.E. Shaw & Co
ACRV icon

D.E. Shaw & Co’s Acrivon Therapeutics ACRV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-31,939
Closed -$157K 3100
2023
Q4
$157K Sell
31,939
-14,811
-32% -$72.9K ﹤0.01% 2720
2023
Q3
$447K Sell
46,750
-160
-0.3% -$1.53K ﹤0.01% 2348
2023
Q2
$608K Sell
46,910
-14,986
-24% -$194K ﹤0.01% 2273
2023
Q1
$785K Buy
+61,896
New +$785K ﹤0.01% 2323